| 000 | 01804 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516220237.0 | ||
| 264 | 0 | _c20141028 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-014-2510-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAggarwal, Rahul | |
| 245 | 0 | 0 |
_aImpact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cAug 2014 |
||
| 300 |
_a359-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aGrabowsky, Jennifer | |
| 700 | 1 | _aStrait, Noah | |
| 700 | 1 | _aCockerill, Alyson | |
| 700 | 1 | _aMunster, Pamela | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 74 _gno. 2 _gp. 359-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-014-2510-0 _zAvailable from publisher's website |
| 999 |
_c23924107 _d23924107 |
||